InvestorsHub Logo
Followers 2
Posts 660
Boards Moderated 0
Alias Born 02/12/2018

Re: None

Friday, 06/22/2018 11:16:19 AM

Friday, June 22, 2018 11:16:19 AM

Post# of 18220
Noreen is now the CEO of Cytocom. She needs to focus on that, and step away from IMUN. IMUN (thanks to Noreens work), has everything in place to continue forward with a new CEO. It is difficult for One person to try to do everything for one company, especially when you don't deligate out things you are not good at. But to try to do it for 2 companies? Seriously. It is clear, Noreen, a very long time ago (Dec 2017 shareholder letter), made the decision to leave IMUN and go to Cytocom. That was 6 months ago it was put out IMUN was looking to replace her as CEO. It is time to expedite that search. IMUN needs a CEO that has one thing, and only one thing he or she is focused on...IMUN. Hopefully the new CEO, understands the importance of good PR and has a sense of true accountability to its shareholders and keeping IMUNs stock at the value it should be. For now, we can only wait. Buy what you can low, one day, IMUN WILL BE VALUED ACCORDINGLY. HOLD THE LINE SPARTANS